The European Commission for the Control of Foot-and-Mouth Disease (EuFMD)

Special Committee on Biorisk Management (SCBRM)

The Special Committee on Biorisk Management (SCBRM) provides guidance on training including the Minimum Standard. It supports the needs of the FMD Biorisk management community. Therefore providing assistance to training initiatives of the commission It aims to  maintain an overview of development in biocontainment and improve the channel of communication with experts in member nations who have FMDV Biorisk management responsibilities.




Kirsten Tjørnehøj (Chairperson)


Senior Adviser Biosafety Officer, Division for Diagnostics and Scientific Advice, National Veterinary Institute Technical University of Denmark

Ulrika Allard


Biosafety Officer, Swedish National Veterinary Institute

Cesare Bernieri


Researcher, Instituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna (IZSLER)

Michael Eschbaumer


Head of FMD National Reference Laboratory, Friedrich-Loeffler Institute

Graeme Harkess

United Kingdom

Biosafety Officer, The Pirbright Institute

Stephan Karlen


Biosafety Scientific Officer, The Institute of Virology and Immunology (IVI)

Douwe Kuperus


Biosafety Officer, Wageningen Veterinary Research

Ronan O’Neill


Head of the Virology Division, Department of Food, Agriculture and the Marine, Ireland

Gonzalo Pascual


Head of Biosecurity and Biocontainment and Director of the FAO Reference Center on Biological Risk Management, Centro De Investigación en Sanidad Animal

Minimum standards for Laboratories working with Foot-and-Mouth Disease virus in vitro and in vivo

On the 28th April 2009, the Minimum Standards for Laboratories working with Foot-and-mouth disease virus in vitro and in vivo" was adopted at the 38th General Session of EUFMD. The Minimums Standards had superseded the prior Standards (1993 and 1985). During the 40th General Session of the EuFMD Commission, the Minimum Standards were further revised.

Revisions had been introduced into the new “MBRM Standards for FMD Contingency laboratories”. The technical content of the “Minimum Standards for Laboratories working with FMDV in vitro and in vivo” had been left unchanged, except for minor clarifications and the now consistent use of the term “Restricted Zone” for all areas where infective FMDV is or might be handled.

  • Read about the Minimum Standards here (version 4.2bis)